Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

Heart failure is not associated with an increased risk of cancer

No Higher Cancer Risk Seen for Heart Failure Patients

0
After a median 20 years of follow-up, heart failure not associated with cancer incidence
Most people in the United States are unaware of national cancer drug shortages

Most Patients Are Unaware of Drug Cancer Shortages

0
Majority say they want to know about even minor consequences of cancer drug substitutions
Overweight and obesity may be contributing to specific malignancies at younger ages

Overweight, Obesity Contributing to Cancers in Young Adults

0
Murine models suggest excessive weight increases cancer incidence and accelerates development

March 2018 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for March 2018. This roundup includes...
A small number of academic-affiliated radiation oncology departments report involvement with formal teaching of medical students

Radiation Oncology Missing in Medical School Education

0
Survey reveals ideas for more 'robust involvement' in undergraduate medical education
Cancer survivors are more likely to have difficulty accessing and affording health care

ACA Has Provided Better Access to Care for Cancer Survivors

0
From 2010 to 2016, decrease seen each year in proportion of survivors reporting delayed medical care
A history of cancer is associated with fatigability and poor endurance

History of Cancer Tied to Lower Endurance, Higher Fatigability

0
Fatigability and poor endurance significantly higher in older adults with cancer history
Higher plasma concentration of 25-hydroxyvitamin D is associated with reduced risk of total cancer in a Japanese population

Vit D Concentration Associated With Reduced Risk of Cancer

0
Inverse correlation for plasma 25-hydroxyvitamin D concentration with total cancer, liver cancer
The National Comprehensive Cancer Network often makes recommendations for new molecular entities beyond the indications approved by the U.S. Food and Drug Administration

NCCN Recommends New Drugs Beyond FDA-Approved Indications

0
NCCN recommended 47 FDA-approved drugs for 113 indications; 39 percent were extra recommendations
There is little evidence for the clinical validity or utility of circulating tumor DNA assays for solid tumors

Limited Evidence for Clinical Validity, Utility of ctDNA

0
No evidence for circulating tumor DNA assays in early-stage cancer, residual disease detection